Fig. 2
From: Vogt–Koyanagi–Harada disease following BCG vaccination and tuberculosis
Images of the right eye and left eye of Patient 1. a, b Four days after initiation of steroid therapy, serous retinal detachment has been resolved in the left eye. c Late-phase FA (18 min) of the right eye shows hyperfluorescent dots. d Late-phase FA (18 min) of the left eye shows decrease in multiple punctuate hyperfluorescent lesions and multilobular pools of dye. e, f Ten days after initiation of steroid therapy, late-phase FA (9 min) of the right eye shows increase in multilobular pools of dye. Late-phase FA (7 min) of the left eye shows decrease in multiple punctuate hyperfluorescent lesions. g EDI-OCT image of the right eye shows serous retinal detachment, subretinal cystoid spaces, and subretinal septa separating the cystoid space from subretinal fluid. Chroidal thickness = 564 µm. h EDI-OCT image of the left eye shows decrease in serous retinal detachment and complete resolution of subretinal cystoid spaces. EDI-OCT reveals hyper-reflective lesions at the level of the retinal pigment epithelium (RPE) with disruption of the inner segment/outer segment (IS/OS) line (Dalen-Fuchs nodule) (red arrow) and discontinuous IS/OS line (white arrow). Choroidal thickness = 541 µm